"Breakthrough Treatment Offers Hope for Neuroferritinopathy Patients"
Neuroferritinopathy, a rare genetic brain condition causing a build-up of iron, has trapped four sisters in their bodies, leaving them unable to communicate or move. A drugs trial at Cambridge University aims to repurpose an existing drug to draw out the iron and potentially halt, reverse, or even "cure" the disease. If successful, the trial could offer hope for patients with this condition and pave the way for treating other conditions linked to iron build-up in the brain.